Treatment of Relapsing Remitting MS/Disease Modifying Therapies: Efficacy and Side Effects
Benjamin Segal, MD, describes FDA-approved therapies for multiple sclerosis that have been proven to reduce the odds of a relapse, delay disability progression and limit new disease activity.
